Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3.
Coppo R, Orso F, Virga F, Dalmasso A, Baruffaldi D, Nie L, Clapero F, Dettori D, Quirico L, Grassi E, Defilippi P, Provero P, Valdembri D, Serini G, Sadeghi MM, Mazzone M, Taverna D. Coppo R, et al. Among authors: provero p. Cancer Lett. 2021 Jul 10;510:13-23. doi: 10.1016/j.canlet.2021.04.005. Epub 2021 Apr 13. Cancer Lett. 2021. PMID: 33862151 Free PMC article.
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pittà C, Pinatel E, Stadler MB, Provero P, Bernengo MG, Osman I, Taverna D. Penna E, et al. Among authors: provero p. EMBO J. 2011 May 18;30(10):1990-2007. doi: 10.1038/emboj.2011.102. Epub 2011 Apr 5. EMBO J. 2011. PMID: 21468029 Free PMC article.
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.
Cimino D, De Pittà C, Orso F, Zampini M, Casara S, Penna E, Quaglino E, Forni M, Damasco C, Pinatel E, Ponzone R, Romualdi C, Brisken C, De Bortoli M, Biglia N, Provero P, Lanfranchi G, Taverna D. Cimino D, et al. Among authors: provero p. FASEB J. 2013 Mar;27(3):1223-35. doi: 10.1096/fj.12-214692. Epub 2012 Dec 11. FASEB J. 2013. PMID: 23233531 Free article. Clinical Trial.
148 results